Haemonetics CorporationHAENYSE
Loading
Operating Income Growth Recovery in ProgressRecovering
Percentile Rank71
5Y CAGR+7.8%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

5Y CAGR
+7.8%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthRecovering
PeriodValue
202534.53%
20245.67%
202393.23%
2022-10.02%
2021-13.16%
202023.71%
201948.77%
2018389.75%
201755.89%
2016-208.39%